Phosphoglycerate kinase: structural aspects and functions, with special emphasis on the enzyme from Kinetoplastea
- PMID: 33234025
- PMCID: PMC7729029
- DOI: 10.1098/rsob.200302
Phosphoglycerate kinase: structural aspects and functions, with special emphasis on the enzyme from Kinetoplastea
Abstract
Phosphoglycerate kinase (PGK) is a glycolytic enzyme that is well conserved among the three domains of life. PGK is usually a monomeric enzyme of about 45 kDa that catalyses one of the two ATP-producing reactions in the glycolytic pathway, through the conversion of 1,3-bisphosphoglycerate (1,3BPGA) to 3-phosphoglycerate (3PGA). It also participates in gluconeogenesis, catalysing the opposite reaction to produce 1,3BPGA and ADP. Like most other glycolytic enzymes, PGK has also been catalogued as a moonlighting protein, due to its involvement in different functions not associated with energy metabolism, which include pathogenesis, interaction with nucleic acids, tumorigenesis progression, cell death and viral replication. In this review, we have highlighted the overall aspects of this enzyme, such as its structure, reaction kinetics, activity regulation and possible moonlighting functions in different protistan organisms, especially both free-living and parasitic Kinetoplastea. Our analysis of the genomes of different kinetoplastids revealed the presence of open-reading frames (ORFs) for multiple PGK isoforms in several species. Some of these ORFs code for unusually large PGKs. The products appear to contain additional structural domains fused to the PGK domain. A striking aspect is that some of these PGK isoforms are predicted to be catalytically inactive enzymes or 'dead' enzymes. The roles of PGKs in kinetoplastid parasites are analysed, and the apparent significance of the PGK gene duplication that gave rise to the different isoforms and their expression in Trypanosoma cruzi is discussed.
Keywords: Trypanosoma; domains; metabolism; moonlighting protein; phosphoglycerate kinase; protists.
Conflict of interest statement
We declare we have no competing interests.
Figures
















Similar articles
-
Closed structure of phosphoglycerate kinase from Thermotoga maritima reveals the catalytic mechanism and determinants of thermal stability.Structure. 1997 Nov 15;5(11):1475-83. doi: 10.1016/s0969-2126(97)00297-9. Structure. 1997. PMID: 9384563
-
Crystal structures of substrates and products bound to the phosphoglycerate kinase active site reveal the catalytic mechanism.Biochemistry. 1998 Mar 31;37(13):4429-36. doi: 10.1021/bi9724117. Biochemistry. 1998. PMID: 9521762
-
Molecular analysis of phosphoglycerate kinase in Trypanoplasma borreli and the evolution of this enzyme in kinetoplastida.Gene. 1998 Sep 14;217(1-2):91-9. doi: 10.1016/s0378-1119(98)00356-4. Gene. 1998. PMID: 9795157
-
Phosphoglycerate kinase.Philos Trans R Soc Lond B Biol Sci. 1981 Jun 26;293(1063):93-104. doi: 10.1098/rstb.1981.0063. Philos Trans R Soc Lond B Biol Sci. 1981. PMID: 6115427 Review.
-
Flexibility and folding of phosphoglycerate kinase.Biochimie. 1990 Jun-Jul;72(6-7):417-29. doi: 10.1016/0300-9084(90)90066-p. Biochimie. 1990. PMID: 2124145 Review.
Cited by
-
Platelets of COVID-19 patients display mitochondrial dysfunction, oxidative stress, and energy metabolism failure compatible with cell death.Res Pract Thromb Haemost. 2023 Sep 28;7(7):102213. doi: 10.1016/j.rpth.2023.102213. eCollection 2023 Oct. Res Pract Thromb Haemost. 2023. PMID: 38077825 Free PMC article.
-
Recombinant Actifensin and Defensin-d2 Induce Critical Changes in the Proteomes of Multidrug-Resistant Pseudomonas aeruginosa and Candida albicans.Microbiol Spectr. 2022 Oct 26;10(5):e0206222. doi: 10.1128/spectrum.02062-22. Epub 2022 Sep 22. Microbiol Spectr. 2022. PMID: 36135381 Free PMC article.
-
BONCAT-iTRAQ Labelling Reveals Molecular Markers of Adaptive Responses in Toxoplasma gondii to Pyrimethamine Treatment.Pathogens. 2024 Oct 8;13(10):879. doi: 10.3390/pathogens13100879. Pathogens. 2024. PMID: 39452750 Free PMC article.
-
Exploring glycolytic enzymes in disease: potential biomarkers and therapeutic targets in neurodegeneration, cancer and parasitic infections.Open Biol. 2025 Feb;15(2):240239. doi: 10.1098/rsob.240239. Epub 2025 Feb 5. Open Biol. 2025. PMID: 39904372 Free PMC article. Review.
-
A reanalysis and integration of transcriptomics and proteomics datasets unveil novel drug targets for Mekong schistosomiasis.Sci Rep. 2024 Jun 5;14(1):12969. doi: 10.1038/s41598-024-63869-0. Sci Rep. 2024. PMID: 38839835 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources